| Trial ID: | L4140 |
| Source ID: | NCT02541734
|
| Associated Drug: |
Gelofusine
|
| Title: |
Effect of Gelofusine on GLP1-receptor Imaging
|
| Acronym: |
GLP1-EX-GELO
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Non-Insulin-Dependent|Diabetes Mellitus
|
| Interventions: |
DRUG: Gelofusine|RADIATION: 111In-exendin 4 SPECT/CT|DRUG: Placebo
|
| Outcome Measures: |
Primary: Renal uptake as measured by uptake of 111In-exendin-4 on SPECT images and without co-infusion of Gelofusine., up to 8 months | Secondary: Pancreas uptake as measured by uptake of 111In-exendin-4 on SPECT images, up to 8 months
|
| Sponsor/Collaborators: |
Sponsor: Radboud University Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2015-08
|
| Completion Date: |
2017-05
|
| Results First Posted: |
|
| Last Update Posted: |
2017-05-31
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02541734
|
